These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7429677)

  • 1. Effects of acute alcohol administration on propranolol absorption.
    Grabowski BS; Cady WJ; Young WW; Emery JF
    Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):317-9. PubMed ID: 7429677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective oral bioavailability of (+/-)-propranolol in the dog. A GC-MS study using a stable isotope technique.
    Walle T; Walle UK
    Res Commun Chem Pathol Pharmacol; 1979 Mar; 23(3):453-64. PubMed ID: 461970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between oral hydralazine and propranolol. I. Changes in absorption, presystemic clearance and splanchnic blood flow.
    Heinzow B; Corbett H; Constantinides S; Bourne R; McLean AJ
    J Pharmacol Exp Ther; 1984 May; 229(2):509-14. PubMed ID: 6716273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption kinetics of sublingually administered propranolol.
    Kates RE
    J Med; 1977; 8(6):393-402. PubMed ID: 272433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of antacids with antiarrhythmics. V. Effect of aluminium hydroxide and magnesium oxide on the bioavailability of quinidine, procainamide and propranolol in dogs.
    Remon JP; Belpaire F; Van Severen R; Braeckman P
    Arzneimittelforschung; 1983; 33(1):117-20. PubMed ID: 6681962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic data of propranolol enantiomers in a comparative human study with (S)- and (R,S)-propranolol.
    Lindner W; Rath M; Stoschitzky K; Semmelrock HJ
    Chirality; 1989; 1(1):10-3. PubMed ID: 2642031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocaine and alcohol interactions in naive and alcohol-pretreated rats.
    Hedaya MA; Pan WJ
    Drug Metab Dispos; 1996 Jul; 24(7):807-12. PubMed ID: 8818580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Likely explanation for longer duration of pharmacological (antianginal) effects of propranolol in relation to its short half-life.
    Ishizaki T
    Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):223-39. PubMed ID: 7367746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theoretical Michaelis-Menten elimination model for propranolol.
    McAinsh J; Gay MA
    Eur J Drug Metab Pharmacokinet; 1985; 10(3):241-5. PubMed ID: 4085525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactive effect of ethanol administration on blood propranolol levels in rats.
    Moriya F; Ishizu H
    Arukoru Kenkyuto Yakubutsu Ison; 1991 Oct; 26(5):360-6. PubMed ID: 1772375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ethanol drinking--absorption kinetics and first-pass effect.
    Fujimiya T; Fukui Y; Komura S
    Nihon Hoigaku Zasshi; 1995 Apr; 49(2):92-103. PubMed ID: 7783393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of portasystemic anastomoses in childhood on propranolol pharmacokinetics].
    Cario WR; Glende M; Lampe D; Buchali K; Bürger K; Grossmann P; Huth M; Rüstow B; Zimmermann HB
    Schweiz Med Wochenschr; 1981 Jul; 111(29):1088-93. PubMed ID: 7268362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant food intake can increase the bioavailability of propranolol by transient inhibition of its presystemic primary conjugation.
    Liedholm H; Melander A
    Clin Pharmacol Ther; 1986 Jul; 40(1):29-36. PubMed ID: 3720177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic nifedipine dosing enhances cephalexin bioavailability and intestinal absorption in conscious rats.
    Berlioz F; Lepére-Prevot B; Julien S; Tsocas A; Carbon C; Rozé C; Farinotti R
    Drug Metab Dispos; 2000 Nov; 28(11):1267-9. PubMed ID: 11038150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective effect of propranolol from alcohol-induced heart muscle damage as assessed by plasma cardiac troponin-t.
    Patel VB; Ajmal R; Sherwood RA; Sullivan A; Richardson PJ; Preedy VR
    Alcohol Clin Exp Res; 2001 Jun; 25(6):882-9. PubMed ID: 11410725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine.
    Kharasch ED; Hoffer C; Whittington D; Sheffels P
    Clin Pharmacol Ther; 2003 Dec; 74(6):543-54. PubMed ID: 14663457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis and disposition of low dose oral propranolol.
    MacKichan JJ; Pyszczynski DR; Jusko WJ
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):531-8. PubMed ID: 674830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No enhanced elimination of propranolol in patients with hyperthyroidism.
    Ishizaki T; Masuno M; Tawara K
    Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):473-85. PubMed ID: 7423023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic extraction of xenobiotics. II. Use of ketoconazole to identify P-glycoprotein/CYP3A-limited bioavailability in the monkey.
    Ward KW; Stelman GJ; Morgan JA; Zeigler KS; Azzarano LM; Kehler JR; McSurdy-Freed JE; Proksch JW; Smith BR
    Drug Metab Dispos; 2004 Feb; 32(2):172-7. PubMed ID: 14744938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.